Shuttle Pharmaceuticals Holdings (SHPH) Payables (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Payables history runs 6 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Payables rose 99.55% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 99.55% YoY), while the FY2025 annual figure was $1.5 million, up 84.75% from the prior year.
• Payables was $1.8 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.8 million in Q1 2026 to a low of $347556.0 in Q1 2024.
• Historically, Payables has averaged $1.0 million across 5 years, with a median of $878859.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Payables plunged 56.52% in 2022, then jumped 158.05% in 2025.
• A 5-year view of Payables shows it stood at $802218.0 in 2022, then increased by 9.55% to $878859.0 in 2023, then fell by 10.47% to $786870.0 in 2024, then jumped by 84.75% to $1.5 million in 2025, then advanced by 23.11% to $1.8 million in 2026.
• The last three Payables figures came in at $1.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.